Filing Details
- Accession Number:
- 0001415889-25-009604
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-02 15:46:01
- Reporting Period:
- 2025-03-31
- Filing Date:
- 2025-04-02
- Accepted Time:
- 2025-04-02 15:46:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1806952 | Lyell Immunopharma Inc. | LYEL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1213029 | W Otis Brawley | C/O Lyell Immunopharma, Inc. 201 Haskins Way, Suite 101 South San Francisco CA 94080 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-31 | 35,640 | $0.56 | 35,640 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
